Mediworld Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 29-12-2024
- Paid Up Capital ₹ 2.00 M
as on 29-12-2024
- Company Age 11 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 38.68%
(FY 2022)
- Profit -94.75%
(FY 2022)
- Ebitda 774.38%
(FY 2022)
- Net Worth 29.27%
(FY 2022)
- Total Assets 7.86%
(FY 2022)
About Mediworld Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.00 M, as per Ministry of Corporate Affairs (MCA) records.
Vinaya Acharya, Sachina Acharya, and Basavaraju Hedni serve as directors at the Company.
- CIN/LLPIN
U24239KA2013PTC068953
- Company No.
068953
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 May 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Davangere, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Mediworld Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sachina Acharya  | Managing Director | 06-May-2013 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vinaya Acharya | Director | 06-May-2013 | Current |
| Basavaraju Hedni | Director | 30-Jan-2015 | Current |
Financial Performance of Mediworld Pharma.
Mediworld Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 38.68% increase. The company also saw a substantial fall in profitability, with a 94.75% decrease in profit. The company's net worth Soared by an impressive increase of 29.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mediworld Pharma?
In 2019, Mediworld Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Green Earth Adventure Resorts Private LimitedActive 16 years 5 months
Sachina Acharya is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mediworld Pharma?
Mediworld Pharma has a workforce of 2 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mediworld Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mediworld Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
